Here are the 10-K annual reports from Bion Envir Techs Inc (BNET) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow BNET and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BNET filings page.
Bion Environmental Technologies, Inc. (BNET) is concentrating on its Ammonia Recovery System (ARS) as a bolt-on solution for existing biogas facilities, rather than developing integrated livestock projects. Bion says its demonstration ARS is ready for final design of a full-scale commercial system, subject to project-specific details, location, and feedstock characteristics. Three initial offtakes represent 250,000 gallons of AB10 fertilizer; two are described as non-binding. A memorandum of understanding with Kimmeridge provides for evaluating ARS at a potential renewable natural gas facility and evaluating and negotiating a joint venture.
BNET reported nil revenue in fiscal 2026 and 2025 and net losses attributable to common stockholders of $1.958 million and $2.380 million, respectively. At June 30, 2026, cash was approximately $3,700; operating activities used $806,000 during the year. The auditor cited substantial doubt about Bion’s ability to continue as a going concern, and management said substantial external funding is required. Management also reported ineffective disclosure controls and a material weakness in financial reporting controls, citing inadequate segregation of duties and lack of timely review and approval of related-party transactions.
Bion Environmental Technologies (BNET) reported continued pre-revenue operations with substantial research-and-development activity focused on fertilizer, water reuse and renewable energy applications of its ARS/Gen3Tech platform. The company holds multiple issued patents and pending applications related to recovering ammonium compounds from wastewater, and states R&D results have supported its objectives. Financially, Bion recorded a large non-cash impairment that reduced shareholders' equity and produced substantial historical losses. The filing discloses limited liquidity, numerous convertible notes and shareholder loans secured by the company’s intellectual property, extensions/forbearance agreements tied to future capital raises, and material risk factors including thin trading, potential dilution, project financing needs, and cybersecurity exposure.